{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T22:12:27Z","timestamp":1791670347499,"version":"4.3.4"},"reference-count":33,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2013,10,28]],"date-time":"2013-10-28T00:00:00Z","timestamp":1382918400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Respirology"],"published-print":{"date-parts":[[2013,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background and objective<\/jats:title>\n                    <jats:p>\n                      The objective of this study was to evaluate the long\u2010term cardiovascular mortality in patients with severe obstructive sleep apnoea (\n                      <jats:styled-content style=\"fixed-case\">OSA<\/jats:styled-content>\n                      ) treated with either continuous positive airway pressure (\n                      <jats:styled-content style=\"fixed-case\">CPAP<\/jats:styled-content>\n                      ) or mandibular advancing device (\n                      <jats:styled-content style=\"fixed-case\">MAD<\/jats:styled-content>\n                      ).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      A non\u2010concurrent cohort study of 570 subjects with severe\n                      <jats:styled-content style=\"fixed-case\">OSA<\/jats:styled-content>\n                      (apnoea\/hypopnoea index (\n                      <jats:styled-content style=\"fixed-case\">AHI<\/jats:styled-content>\n                      )\u2009\u2265\u200930\/h) and a control group of 269 subjects (\n                      <jats:styled-content style=\"fixed-case\">AHI<\/jats:styled-content>\n                      \u2009&lt;\u20095\/h) were followed up for a median of 79 months (interquartile range 76\u201388 months). All patients received\n                      <jats:styled-content style=\"fixed-case\">CPAP<\/jats:styled-content>\n                      initially.\n                      <jats:styled-content style=\"fixed-case\">MAD<\/jats:styled-content>\n                      was offered for those who were non\u2010adherent to\n                      <jats:styled-content style=\"fixed-case\">CPAP<\/jats:styled-content>\n                      . The endpoint was cardiovascular death.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      \u2003Two hundred and eight control subjects, 177 patients treated with\n                      <jats:styled-content style=\"fixed-case\">CPAP<\/jats:styled-content>\n                      , 72 with\n                      <jats:styled-content style=\"fixed-case\">MAD<\/jats:styled-content>\n                      and 212 who declined treatment were analysed. Forty\u2010two patients had a fatal cardiovascular event during the course of the study. The non\u2010apnoeic group had the lowest cardiovascular death rate (0.28 per 100 person\u2010years (95% confidence interval (\n                      <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>\n                      ): 0.08\u20130.71)) followed by the\n                      <jats:styled-content style=\"fixed-case\">CPAP<\/jats:styled-content>\n                      \u2010treated (0.56 per 100 person\u2010years (95%\n                      <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>\n                      : 0.20\u20131.23)) and the\n                      <jats:styled-content style=\"fixed-case\">MAD<\/jats:styled-content>\n                      \u2010treated\n                      <jats:styled-content style=\"fixed-case\">OSA<\/jats:styled-content>\n                      group (0.61 per 100 person\u2010years (95%\n                      <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>\n                      : 0.13\u20131.78)), with the highest cardiovascular mortality rate observed in the untreated\n                      <jats:styled-content style=\"fixed-case\">OSA<\/jats:styled-content>\n                      group (2.1 per 100 person\u2010years (95%\n                      <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>\n                      : 1.37\u20132.92)). Although residual\n                      <jats:styled-content style=\"fixed-case\">AHI<\/jats:styled-content>\n                      for\n                      <jats:styled-content style=\"fixed-case\">MAD<\/jats:styled-content>\n                      \u2010treated patients was significantly higher than\n                      <jats:styled-content style=\"fixed-case\">CPAP<\/jats:styled-content>\n                      \u2010treated patients (16.3\u2009\u00b1\u20095.1\/h vs. 4.5\u2009\u00b1\u20092.3\/h;\n                      <jats:italic>\n                        <jats:styled-content style=\"fixed-case\">P<\/jats:styled-content>\n                      <\/jats:italic>\n                      \u2009&lt;\u20090.001), there was no difference in cardiovascular death rate between the two groups (hazard ratio 1.08 (95%\n                      <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>\n                      : 0.55\u20131.74);\n                      <jats:italic>\n                        <jats:styled-content style=\"fixed-case\">P<\/jats:styled-content>\n                      <\/jats:italic>\n                      \u2009=\u20090.71).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      Both\n                      <jats:styled-content style=\"fixed-case\">CPAP<\/jats:styled-content>\n                      and\n                      <jats:styled-content style=\"fixed-case\">MAD<\/jats:styled-content>\n                      may be equally effective therapy in reducing the risk of fatal cardiovascular events in patients with severe\n                      <jats:styled-content style=\"fixed-case\">OSA<\/jats:styled-content>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/resp.12140","type":"journal-article","created":{"date-parts":[[2013,6,3]],"date-time":"2013-06-03T09:13:16Z","timestamp":1370250796000},"page":"1184-1190","source":"Crossref","is-referenced-by-count":127,"title":["Cardiovascular mortality in obstructive sleep apnoea treated with continuous positive airway pressure or oral appliance: An observational study"],"prefix":"10.1111","volume":"18","author":[{"given":"Anil","family":"Anandam","sequence":"first","affiliation":[{"name":"Division of Pulmonary, Critical Care, and Sleep Medicine Department of Medicine Department of Social and Preventive Medicine Western New York Respiratory Research Center  Buffalo New York USA"},{"name":"School of Medicine and Biomedical Sciences School of Public Health and Health Professions State University of New York at Buffalo  Buffalo New York USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monali","family":"Patil","sequence":"additional","affiliation":[{"name":"Division of Pulmonary, Critical Care, and Sleep Medicine Department of Medicine Department of Social and Preventive Medicine Western New York Respiratory Research Center  Buffalo New York USA"},{"name":"School of Medicine and Biomedical Sciences School of Public Health and Health Professions State University of New York at Buffalo  Buffalo New York USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morohunfolu","family":"Akinnusi","sequence":"additional","affiliation":[{"name":"Division of Pulmonary, Critical Care, and Sleep Medicine Department of Medicine Department of Social and Preventive Medicine Western New York Respiratory Research Center  Buffalo New York USA"},{"name":"School of Medicine and Biomedical Sciences School of Public Health and Health Professions State University of New York at Buffalo  Buffalo New York USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Jaoude","sequence":"additional","affiliation":[{"name":"Division of Pulmonary, Critical Care, and Sleep Medicine Department of Medicine Department of Social and Preventive Medicine Western New York Respiratory Research Center  Buffalo New York USA"},{"name":"School of Medicine and Biomedical Sciences School of Public Health and Health Professions State University of New York at Buffalo  Buffalo New York USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali A.","family":"El\u2010Solh","sequence":"additional","affiliation":[{"name":"Division of Pulmonary, Critical Care, and Sleep Medicine Department of Medicine Department of Social and Preventive Medicine Western New York Respiratory Research Center  Buffalo New York USA"},{"name":"School of Medicine and Biomedical Sciences School of Public Health and Health Professions State University of New York at Buffalo  Buffalo New York USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2013,10,28]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1136\/thx.53.5.341"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.159.2.9803121"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201106-0964OC"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1513\/pats.200709-150MG"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)71141-7"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1513\/pats.200708-119MG"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.2165\/00151829-200504060-00005"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/29.2.244"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00099710"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1159\/000156861"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/lary.20103"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2869.2007.00615.x"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2842.2009.01987.x"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1159\/000324580"},{"key":"e_1_2_6_16_1","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1097\/HJH.0b013e3282f0580f","article-title":"2007 ESH\u2010ESC practice guidelines for the management of arterial hypertension: ESH\u2010ESC Task Force on the management of arterial hypertension","volume":"25","author":"Mancia G","year":"2007","journal-title":"J. Hypertens."},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/28.4.499"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/22.5.667"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-156-2-201201170-00006"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200808-1341OC"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.127.6.2076"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.94.1.9"},{"key":"e_1_2_6_23_1","first-page":"1071","article-title":"Sleep disordered breathing and mortality: eighteen\u2010year follow\u2010up of the Wisconsin sleep cohort","volume":"31","author":"Young T","year":"2008","journal-title":"Sleep"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)71141-7"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.164.10.2101072"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2006.063644"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.sleep.2011.05.004"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.06-0965"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.sleep.2008.06.013"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00011311"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2006.01.008"},{"issue":"4","key":"e_1_2_6_32_1","first-page":"S172","article-title":"Treatment, airway and compliance effects of a titratable oral appliance","volume":"23","author":"Lowe AA","year":"2000","journal-title":"Sleep"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200203-208OC"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.122.2.569"}],"container-title":["Respirology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fresp.12140","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/resp.12140","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T05:01:20Z","timestamp":1696136480000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/resp.12140"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,28]]},"references-count":33,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["10.1111\/resp.12140"],"URL":"https:\/\/doi.org\/10.1111\/resp.12140","archive":["Portico"],"relation":{},"ISSN":["1323-7799","1440-1843"],"issn-type":[{"value":"1323-7799","type":"print"},{"value":"1440-1843","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10,28]]}}}